Venture Capital
Japan’s Mitsubishi Launches $700 Million VC Arm
ByCat Wang,
Forbes Staff
For Midas Newcomers, VC Network Effect Led To Big Gains
Former Contributor
Coatue Veteran Kris Fredrickson Goes It Alone With New Venture Fund
ByIain Martin,
Forbes Staff
The former Coatue and Benchmark investor is back with a new $175 million fund to back a new generation of artificial intelligence startups like Perplexity and Harvey AI.
More From Venture Capital
The Merchant Banking Evolution In Venture Capital
The venture capital playbook is getting a major rewrite. After decades of the traditional model (write checks, offer advice, make introductions), a growing number of funds are morphing into something that looks more like merchant banks than passive investors. They're building internal engineering teams, offering shared services, and getting their hands dirty in the operational trenches of their portfolio companies.
Contributor
Muse Capital Bets Big On Women’s Health And Sports
Muse Capital proves that women VCs who engage female investors to invest in overlooked founders changing how we care, play, and live can reshape the culture of VC.
ByGeri Stengel,
Contributor
How ‘Acquihires’ Are Reshaping Silicon Valley’s AI Investments
The latest example happened last week when Google swooped in to hire Windsurf's CEO and key talent after OpenAI's three billion dollar acquisition deal collapsed.
Contributor
Coatue Veteran Kris Fredrickson Goes It Alone With New Venture Fund
The former Coatue and Benchmark investor is back with a new $175 million fund to back a new generation of artificial intelligence startups like Perplexity and Harvey AI.
ByIain Martin,
Forbes Staff
The Cloud Is Breaking. This Finnish Startup Is Building What Comes Next.
As ransomware, regulation, and geopolitics reshape cloud infrastructure, Finland’s SpaceTime is building a sovereign system designed to survive collapse.
Contributor
The AI Gold Rush Hits Insurance And Where Investors Are Doubling Down
Startups are rushing to build AI tools to automate workflows across finance, software engineering, and nearly every other field. One industry that often gets overlooked but is seeing its own AI revolution is the insurance industry. Notorious for manual workflows, 100+ page documents, and poor customer service, many VCs believe the industry is ripe for AI disruption.
Contributor
AI Startup LangChain Is In Talks To Raise $100 Million
The startup, which sources say is raising at a $1.1 billion valuation, helps developers at companies like Klarna and Rippling use off-the-shelf AI models to create new applications.
Forbes Staff
Compounding Pharmacies: The $10 Billion Disruption Backed By PE And VC
Private equity and VC are pouring billions into compounding pharmacies—reshaping pharma’s future through personalized medicine and regulatory arbitrage.
Contributor
The Hottest VC Deals Today Are No Revenue, No Product, Just All-Star AI Teams And Mega Rounds
When former OpenAI CTO Mira Murati’s six-month-old startup Thinking Machines Lab successfully raised 2 billion dollars at a 10 billion dollar valuation, it crystallized a fundamental shift in how AI companies compete for talent. But this astronomical funding round isn’t just about one company’s ambitions - it's the direct result of a compensation arms race that began with Meta's desperate hundred-million-dollar recruiting spree.
Contributor
How Compounding Pharmacies Are Challenging Big Pharma On GLP-1 Drugs And Drug Patents
As demand for GLP-1 drugs grows, compounding pharmacies and telehealth startups are challenging Big Pharma’s grip on pricing, patents, and access to care.
Contributor
Can Gen Z Fix Construction’s Labor Crisis? This Startup Is Betting Yes
This startup is betting with its tech platform, a new generation of workers can fix construction's labor crisis. Is blue-collar work the new greenback grind for Gen Z ?
Contributor
VCs Are Turning Away From The ‘Fixer-Upper’ Founder
Faster. Better. Smarter. Smoother. Why VCs are turning away from "incremental improvers" in favour of paradigm-shifting experiences
Contributor
EQT Shakes Up Venture Team As It Ramps Up US Investments
EQT Shakes Up Venture Team As It Heads To New York
ByIain Martin,
Forbes Staff
SpotitEarly’s New Early Cancer Detection Breath Test Is Powered By AI And Dogs
SpotitEarly’s at-home breath test pairs canine scent detection with AI to deliver non-invasive, affordable early cancer screening for breast, lung, prostate and more.
Contributor
$40 Mic To $650 Million Firm: How Harry Stebbings Is Rewiring European Venture Capital
He started off interviewing the world’s top venture capitalists on a podcast. Then he launched his own firm. Now Harry Stebbings is bringing a Silicon Valley-style shake up to the continent’s traditionally cautious investment scene.
ByZoya Hasan,
Forbes Staff
Julie Bornstein’s Daydream Is Leading The Agentic AI Fashion Shopping Revolution Starting With 8,000 Brands
Julie Bornstein’s Daydream is redefining AI fashion shopping with agentic AI, real-time personalization, and a discovery-first model powered by 8,000 brands.
Contributor
Making Recruiters AI-Powered, Not AI-Replaced
Silicon Valley has a new obsession: eliminating humans from recruiting. Venture capitalists have poured billions into AI-powered resume scanners, chatbots that conduct interviews, and algorithms that promise to find perfect candidates without human intervention. The pitch is seductive: Why pay expensive recruiters when artificial intelligence can do it faster and cheaper?
Contributor
This Startup Wants Its Robots To Operate On Your Eyeballs
Millions of people get cataract surgery every year. Startup ForSight, backed with $125 million in fresh funding, is betting a robot can do it better than humans.
ByAmy Feldman,
Forbes Staff
Notes From A VC Who Doesn’t Fit The Mold
Sharon Vosmek, a San Francisco-based VC, makes her editorial debut with a Forbes column exploring what it takes to start a company, raise capital, and scale.
Contributor
AI Is Catching What Mammograms Miss—And A Vaccine Could Stop Breast Cancer Before It Starts
AI tools like DeepLook are improving dense breast cancer detection, while a Cleveland Clinic vaccine trial offers hope for stopping recurrence before it starts.
Contributor